Latest & greatest articles for tuberculosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on tuberculosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on tuberculosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for tuberculosis

175. Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (2016), 28 - 29 June 2016, Geneva, Switzerland

Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (2016), 28 - 29 June 2016, Geneva, Switzerland Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (‎2016)‎, 28 - 29 June 2016, Geneva, Switzerland JavaScript is disabled for your browser. Some features of this site may not work (...) without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (‎2016)‎, 28 - 29 June 2016, Geneva, Switzerland View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug

2017 WHO

176. Determining clinical decision thresholds for HIV-positive patients suspected of having tuberculosis

Determining clinical decision thresholds for HIV-positive patients suspected of having tuberculosis Determining clinical decision thresholds for HIV-positive patients suspected of having tuberculosis | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Determining clinical decision thresholds for HIV-positive patients suspected of having tuberculosis Article Text Original EBM Research Determining clinical decision thresholds for HIV

2017 Evidence-Based Medicine (Requires free registration)

177. Diagnosis of Tuberculosis in Adults and Children: Official ATS/IDSA/CDC Clinical Practice Guidelines

Diagnosis of Tuberculosis in Adults and Children: Official ATS/IDSA/CDC Clinical Practice Guidelines Clinical Infectious Diseases Diagnosis of TB in Adults and Children • CID 2017:64 (15 January) • e1 Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children David M. Lewinsohn, 1,a Michael K. Leonard, 2,a Philip A. LoBue, 3,a David L. Cohn, 4 Charles L. Daley (...) Health, Nashville, Tennessee, 14 Wisconsin State Laboratory of Hygiene, Madison, and 15 University of Arkansas for Medical Sciences, Little Rock Background. Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuber- culosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its

2017 American Thoracic Society

178. Interventions to improve contact tracing for tuberculosis in specific groups and in wider populations: an evidence synthesis

Interventions to improve contact tracing for tuberculosis in specific groups and in wider populations: an evidence synthesis Interventions to improve contact tracing for tuberculosis in specific groups and in wider populations: an evidence synthesis Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search

2017 NIHR HTA programme

179. The effect of tuberculosis control in China. (PubMed)

The effect of tuberculosis control in China. China has 1.4 million new cases of tuberculosis every year, more than any country except India. A new tuberculosis control project based on short-course chemotherapy was introduced in half the country in 1991, after a national survey of tuberculosis prevalence in 1990. Another survey was done in 2000 to re-evaluate the national tuberculosis burden, providing the opportunity to assess the effect of the control project.The survey in 2000 identified (...) 375599 eligible individuals at 257 investigation points chosen from all 31 mainland provinces by stratified random sampling. Children (aged 0-14 years) were suspected of having tuberculosis if they had an induration of 10 mm or greater after a tuberculin skin test, and an abnormal fluorograph. Adults were suspected if they had a persistent cough, abnormal fluorograph, or both. Tuberculosis was diagnosed by chest radiograph, sputum-smear microscopy, and culture.365097 people were examined (97

2017 Lancet

180. Efficacy of direct hemoperfusion with a polymyxin B‐immobilized fiber column in miliary tuberculosis (PubMed)

Efficacy of direct hemoperfusion with a polymyxin B‐immobilized fiber column in miliary tuberculosis A 75-year-old woman presented with a 10-day history of intermittent fever, general fatigue, and progressive dyspnea. Although she had a low PaO2/FIO2 ratio, the cause of acute respiratory distress syndrome was not clear until day 9 in hospital.We treated the patient with direct hemoperfusion with a polymyxin B-immobilized fiber column incidentally; the PaO2/FIO2 ratio improved following (...) this therapy. Acid-fast bacilli, which were not seen in the sputum on admission, were detected in cultures from sputum, urine, bone marrow, liver biopsy, and blood samples, with a real-time polymerase chain reaction assay confirming tuberculosis. She was immediately transferred to a specialized tuberculosis hospital, and after a 3-month treatment, was discharged.Treatment with polymyxin B-immobilized fiber column may provide good results for pulmonary oxygenation in acute respiratory distress syndrome

Full Text available with Trip Pro

2016 Acute medicine & surgery